| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |